300676 华大基因
已收盘 01-13 15:00:00
资讯
新帖
简况
华大基因（300676）披露关于控股股东部分股份解除质押及再质押的公告，1月5日股价上涨4.59%
证券之星 · 01-05
华大基因（300676）披露关于控股股东部分股份解除质押及再质押的公告，1月5日股价上涨4.59%
华大基因控股股东华大控股新增质押240万股股份
中金财经 · 2025-12-22
华大基因控股股东华大控股新增质押240万股股份
AI+基因组学深度融合，华大基因（300676.SZ）荣获“年度卓越人工智能应用企业”
格隆汇 · 2025-12-22
AI+基因组学深度融合，华大基因（300676.SZ）荣获“年度卓越人工智能应用企业”
华大基因（300676）披露关于控股股东部分股份解除质押的公告，12月15日股价下跌1.51%
证券之星 · 2025-12-15
华大基因（300676）披露关于控股股东部分股份解除质押的公告，12月15日股价下跌1.51%
华大基因控股股东华大控股解除质押1467万股股份
中金财经 · 2025-12-12
华大基因控股股东华大控股解除质押1467万股股份
华大基因：截至2025年9月30日股东总数为67,903人
证券之星 · 2025-12-11
华大基因：截至2025年9月30日股东总数为67,903人
华大基因（300676）披露2026年度开展外汇套期保值业务计划，11月13日股价下跌0.65%
证券之星 · 2025-11-13
华大基因（300676）披露2026年度开展外汇套期保值业务计划，11月13日股价下跌0.65%
华大基因最新公告：副总经理李宁因工作安排原因辞任
证券之星 · 2025-11-12
华大基因最新公告：副总经理李宁因工作安排原因辞任
11月3日华大基因现1笔折价10%的大宗交易 合计成交442.7万元
证券之星 · 2025-11-03
11月3日华大基因现1笔折价10%的大宗交易 合计成交442.7万元
华大基因：发布BISCUIT-seq多组学检测技术
证券之星 · 2025-11-03
华大基因：发布BISCUIT-seq多组学检测技术
华大基因公布国际专利申请：“一种染色体非整倍体的分析方法及应用”
证券之星 · 2025-11-02
华大基因公布国际专利申请：“一种染色体非整倍体的分析方法及应用”
华大基因(300676)9月30日股东户数6.79万户，较上期增加5.58%
证券之星 · 2025-10-24
华大基因(300676)9月30日股东户数6.79万户，较上期增加5.58%
华大基因(300676.SZ)发布前三季度业绩，归母净亏损2138.7万元
智通财经 · 2025-10-23
华大基因(300676.SZ)发布前三季度业绩，归母净亏损2138.7万元
华大基因最新公告：全资子公司与关联方联合申报科技项目
证券之星 · 2025-10-23
华大基因最新公告：全资子公司与关联方联合申报科技项目
华大基因：未与沐曦在AI领域有合作
证券之星 · 2025-10-22
华大基因：未与沐曦在AI领域有合作
华大基因：股东减持期间为2025年9月4日—2025年12月3日
证券之星 · 2025-10-22
华大基因：股东减持期间为2025年9月4日—2025年12月3日
新股前瞻|带着40亿估值二次递表，安诺优达能否成为“港市华大基因”？
智通财经 · 2025-10-10
新股前瞻|带着40亿估值二次递表，安诺优达能否成为“港市华大基因”？
华大基因：9月22日高管汪建减持股份合计1673.27万股
证券之星 · 2025-09-22
华大基因：9月22日高管汪建减持股份合计1673.27万股
股市必读：华大基因（300676）9月18日董秘有最新回复
证券之星 · 2025-09-19
股市必读：华大基因（300676）9月18日董秘有最新回复
华大基因：i99智健系统拓展精准健康管理
证券之星 · 2025-09-18
华大基因：i99智健系统拓展精准健康管理
加载更多
公司概况
公司名称：
深圳华大基因股份有限公司
所属行业：
专业技术服务业
上市日期：
2017-07-14
主营业务：
深圳华大基因股份有限公司的主营业务是为科研机构、企事业单位、医疗机构、社会卫生组织等提供研究服务、精准医学检测综合解决方案和健康管理服务。公司的主要产品是生育健康基础研究和临床应用服务、肿瘤与慢病防控及转化医学类服务、感染防控基础研究和临床应用服务、多组学大数据服务与合成业务、精准医学检测综合解决方案。
发行价格：
13.64
{"stockData":{"symbol":"300676","market":"SZ","secType":"STK","nameCN":"华大基因","latestPrice":58.01,"timestamp":1768287789000,"preClose":54.7,"halted":0,"volume":42526059,"delay":0,"changeRate":0.0605,"floatShares":416000000,"shares":418000000,"eps":-1.9123,"marketStatus":"已收盘","change":3.31,"latestTime":"01-13 15:00:00","open":56.81,"high":65,"low":55.7,"amount":2551000000,"amplitude":0.17,"askPrice":58.02,"askSize":20,"bidPrice":58.01,"bidSize":118,"shortable":0,"etf":0,"ttmEps":-1.9123,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768354200000},"marketStatusCode":5,"adr":0,"adjPreClose":54.7,"symbolType":"stock","openAndCloseTimeList":[[1768267800000,1768275000000],[1768280400000,1768287600000]],"highLimit":60.17,"lowLimit":49.23,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":418317075,"isCdr":false,"pbRate":2.48,"roa":"--","roe":"--","epsLYR":-2.189,"committee":0.336181,"marketValue":24267000000,"turnoverRate":0.1022,"status":0,"floatMarketCap":24135000000},"requestUrl":"/m/hq/s/300676","defaultTab":"news","newsList":[{"id":"2601887116","title":"华大基因（300676）披露关于控股股东部分股份解除质押及再质押的公告，1月5日股价上涨4.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601887116","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601887116?lang=zh_cn&edition=full","pubTime":"2026-01-05 22:29","pubTimestamp":1767623359,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘，华大基因报收于47.44元，较前一交易日上涨4.59%，最新总市值为198.45亿元。公司近日发布公告称，控股股东深圳华大基因科技有限公司于2025年12月31日解除质押7,700,000股，占公司总股本1.84%。本次变动后，华大控股累计质押股份占其所持股份比例为73.05%，占公司总股本21.75%。公司控股股东及其一致行动人质押股份比例超过50%但未达80%，不存在平仓风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500040199.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0197","BK0042","300676","BK0221","BK0196"],"gpt_icon":0},{"id":"2593483905","title":"华大基因控股股东华大控股新增质押240万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2593483905","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593483905?lang=zh_cn&edition=full","pubTime":"2025-12-22 17:15","pubTimestamp":1766394941,"startTime":"0","endTime":"0","summary":"中访网数据 深圳华大基因股份有限公司于近日发布公告，披露其控股股东深圳华大基因科技有限公司部分股份质押情况。根据公告，华大控股于2025年12月19日将其持有的240万股公司股份办理了质押，占其所持股份的1.93%，占公司总股本的0.57%。本次质押股份为非限售股，质权人为兴业银行股份有限公司深圳分行，质押用途为满足华大控股及其控股子公司自身生产经营的资金需求，质押到期日为办理解除质押登记手续之日止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251222/31881439.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0046","BK0197","BK0221","BK0042","300676","BK0196"],"gpt_icon":0},{"id":"2593972488","title":"AI+基因组学深度融合，华大基因（300676.SZ）荣获“年度卓越人工智能应用企业”","url":"https://stock-news.laohu8.com/highlight/detail?id=2593972488","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593972488?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:59","pubTimestamp":1766393974,"startTime":"0","endTime":"0","summary":"荣获“年度卓越人工智能应用企业”，绝非华大基因AI故事的终点，而是一个更具象的新起点。","market":"sh","thumbnail":"https://img2.gelonghui.com/b17e2-468a18b6-ae42-4fc2-868d-4ed3d0e97e8e.jpg?guru_height=720&guru_width=1280&guru_size=154189","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/b17e2-468a18b6-ae42-4fc2-868d-4ed3d0e97e8e.jpg?guru_height=720&guru_width=1280&guru_size=154189"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/3419014","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK0046","BK0197","BK0196","161631","BK0221","BK0042","300676"],"gpt_icon":0},{"id":"2591617487","title":"华大基因（300676）披露关于控股股东部分股份解除质押的公告，12月15日股价下跌1.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591617487","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591617487?lang=zh_cn&edition=full","pubTime":"2025-12-15 18:07","pubTimestamp":1765793230,"startTime":"0","endTime":"0","summary":"截至2025年12月15日收盘，华大基因报收于45.02元，较前一交易日下跌1.51%，最新总市值为188.33亿元。该股当日开盘45.6元，最高45.7元，最低44.93元，成交额达1.38亿元，换手率为0.73%。公司近日发布公告称，控股股东深圳华大基因科技有限公司已将其持有的14,670,000股公司股份办理了解除质押手续，占公司总股本的3.51%。本次解除质押后，华大控股及其一致行动人合计质押股份占其所持股份比例为67.99%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500023865.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0221","BK0197","BK0042","300676","BK0196","BK0046"],"gpt_icon":0},{"id":"2590757228","title":"华大基因控股股东华大控股解除质押1467万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2590757228","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590757228?lang=zh_cn&edition=full","pubTime":"2025-12-12 17:43","pubTimestamp":1765532596,"startTime":"0","endTime":"0","summary":"中访网数据 深圳华大基因股份有限公司于2025年12月12日发布公告，其控股股东深圳华大基因科技有限公司近期办理了部分股份解除质押手续。本次解除质押股份共计14,670,000股，占华大控股所持股份的11.78%，占公司总股本的3.51%。 本次解除质押后，控股股东华大控股及其一致行动人合计持有公司股份131,026,534股，占总股本的31.32%。公告指出，未来半年内控股股东及其一致行动人到期的质押股份涉及融资余额约15.16亿元，未来一年内到期的涉及融资余额约23.26亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251212/31862750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300676","BK0221","BK0046","BK0197","BK0196","BK0042"],"gpt_icon":0},{"id":"2590596393","title":"华大基因：截至2025年9月30日股东总数为67,903人","url":"https://stock-news.laohu8.com/highlight/detail?id=2590596393","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590596393?lang=zh_cn&edition=full","pubTime":"2025-12-11 16:45","pubTimestamp":1765442746,"startTime":"0","endTime":"0","summary":"证券之星消息，华大基因(300676)12月11日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，您好！敬请发布截至今天10月31日公司的股东户数信息华大基因回复：您好，感谢您对华大基因的关注。根据公司发布的《2025年三季度报告》，截至2025年9月30日，公司的普通股股东总数为67,903人。关于股东人数的更新信息，请您留意公司后续在巨潮资讯网发布的定期报告。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100025353.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300676","BK0221","BK0046","BK0197","BK0196","BK0042"],"gpt_icon":0},{"id":"2583855071","title":"华大基因（300676）披露2026年度开展外汇套期保值业务计划，11月13日股价下跌0.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583855071","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583855071?lang=zh_cn&edition=full","pubTime":"2025-11-13 17:28","pubTimestamp":1763026085,"startTime":"0","endTime":"0","summary":"截至2025年11月13日收盘，华大基因报收于49.18元，较前一交易日下跌0.65%，最新总市值为205.73亿元。该股当日开盘49.3元，最高49.35元，最低48.5元，成交额达2.52亿元，换手率为1.24%。公司近日发布公告称，已于2025年11月12日召开2025年第二次临时股东会，审议通过了关于2026年度开展外汇套期保值业务的议案。公告显示，会议采用现场与网络投票结合方式召开，出席股东代表股份占总表决权股份的39.1127%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300029957.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0197","BK0196","BK0221","BK0042","300676"],"gpt_icon":0},{"id":"2582612327","title":"华大基因最新公告：副总经理李宁因工作安排原因辞任","url":"https://stock-news.laohu8.com/highlight/detail?id=2582612327","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582612327?lang=zh_cn&edition=full","pubTime":"2025-11-12 18:41","pubTimestamp":1762944085,"startTime":"0","endTime":"0","summary":"华大基因(300676.SZ)公告称，公司董事、副总经理李宁因工作安排原因申请辞去公司副总经理职务，辞任后继续担任公司董事，同时继续在公司的控股子公司担任职务。李宁原定任期为2024年6月18日至2027年6月17日，直接持有公司股份122,600股，通过公司第二期员工持股计划持有103.788万份持股计划份额。其辞任事项不会影响公司的日常经营和相关业务的管理运作。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200033363.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["82331","02331","LU0572944931.SGD","BK0196","LU0541502299.USD","LU1102505762.USD","LU0823426308.USD","300676","LU1102505929.USD","BK0046","BK1502","LU0541501648.USD","BK1589","LU1880383366.USD","LNNGY","BK1227","LU0048580855.USD","LU0327786744.USD","LU0072462343.USD","LU2125910500.SGD","BK0221","LU2045819591.USD","BK0042","BK1512","LU1048588211.SGD","LU0370786039.SGD","BK1610","LU0823426480.USD","LU0348805143.USD","BK0197","LU0593848301.USD"],"gpt_icon":0},{"id":"2580260041","title":"11月3日华大基因现1笔折价10%的大宗交易 合计成交442.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580260041","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580260041?lang=zh_cn&edition=full","pubTime":"2025-11-03 17:18","pubTimestamp":1762161519,"startTime":"0","endTime":"0","summary":"证券之星消息，11月3日华大基因发生大宗交易，交易数据如下：大宗交易成交价格44.27元，相对当日收盘价折价10%，成交10万股，成交金额442.7万元，买方营业部为机构专用，卖方营业部为华福证券有限责任公司华南分公司。近三个月该股共发生2笔大宗交易，合计成交6221.0手，折价成交2笔。截至2025年11月3日收盘，华大基因报收于49.19元，下跌0.02%，换手率1.54%，成交量6.41万手，成交额3.18亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300023193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0042","BK0221","BK0196","300676","BK0046"],"gpt_icon":0},{"id":"2580267587","title":"华大基因：发布BISCUIT-seq多组学检测技术","url":"https://stock-news.laohu8.com/highlight/detail?id=2580267587","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580267587?lang=zh_cn&edition=full","pubTime":"2025-11-03 16:39","pubTimestamp":1762159150,"startTime":"0","endTime":"0","summary":"证券之星消息，华大基因11月03日在投资者关系平台上答复投资者关心的问题。华大基因回复：1）单癌种早筛方面：公司在2025年第三季度发布了血液无创胃癌基因检测服务和华妍康宫颈癌DNA甲基化检测服务，现有高发癌种早期筛查与诊断解决方案进一步完善。为解决行业痛点，华大基因自主研发了BISCUIT-seq多组学检测技术，并于日前在2025年度中国临床肿瘤学会学术年会上进行了发布。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300021806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","300676","BK0046","BK0042","BK0221","BK0196"],"gpt_icon":0},{"id":"2580471465","title":"华大基因公布国际专利申请：“一种染色体非整倍体的分析方法及应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2580471465","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580471465?lang=zh_cn&edition=full","pubTime":"2025-11-02 05:21","pubTimestamp":1762032074,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示华大基因（300676）公布了一项国际专利申请，专利名为“一种染色体非整倍体的分析方法及应用”，专利申请号为PCT/CN2024/089201，国际公布日为2025年10月30日。专利详情如下：图片来源：世界知识产权组织（WIPO）今年以来华大基因已公布的国际专利申请7个，较去年同期减少了36.36%。结合公司2025年中报财务数据，今年上半年公司在研发方面投入了2.28亿元，同比减9.05%。数据来源：企查查以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200001022.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300676","BK0042","BK0196","BK0197","BK0046","BK0221"],"gpt_icon":0},{"id":"2577993125","title":"华大基因(300676)9月30日股东户数6.79万户，较上期增加5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577993125","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577993125?lang=zh_cn&edition=full","pubTime":"2025-10-24 17:16","pubTimestamp":1761297410,"startTime":"0","endTime":"0","summary":"证券之星消息，近日华大基因披露，截至2025年9月30日公司股东户数为6.79万户，较6月30日增加3588.0户，增幅为5.58%。在医疗服务行业个股中，华大基因股东户数高于行业平均水平，截至9月30日，医疗服务行业平均股东户数为4.56万户。从股价来看，2025年6月30日至2025年9月30日，华大基因区间跌幅为1.23%，在此期间股东户数增加3588.0户，增幅为5.58%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400030699.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","300676","BK0221","BK0046","BK0197","BK0042"],"gpt_icon":0},{"id":"2577585166","title":"华大基因(300676.SZ)发布前三季度业绩，归母净亏损2138.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577585166","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577585166?lang=zh_cn&edition=full","pubTime":"2025-10-23 22:52","pubTimestamp":1761231153,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华大基因(300676.SZ)发布2025年三季度报告，前三季度，公司实现营业收入26.74亿元，同比下降5.39%。归属于上市公司股东净亏损2138.7万元。归属于上市公司股东的扣除非经常性损益净亏损6676.47万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1359092.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"华大基因(300676.SZ)发布前三季度业绩，归母净亏损2138.7万元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0221","BK0197","BK0042","300676","BK0196","BK0046"],"gpt_icon":0},{"id":"2577027363","title":"华大基因最新公告：全资子公司与关联方联合申报科技项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2577027363","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577027363?lang=zh_cn&edition=full","pubTime":"2025-10-23 21:00","pubTimestamp":1761224403,"startTime":"0","endTime":"0","summary":"华大基因(300676.SZ)公告称，全资子公司天津华大医学检验所有限公司拟与关联方杭州华大生命科学研究院、常州新一产生命科技有限公司及其他机构，联合申报“新发突发与重大传染病防控国家科技重大专项”中的“病原体检测专用便捷长读长测序系统开发”项目。该项目总经费1.2亿元，其中申请国拨经费2000万元，联合申报单位自筹经费1亿元。天津华大医学检验所自筹5000万元，参与3个课题，主要承担应用端的病原单分子检测试剂盒、配套算法和数据库的开发以及自动化应用的研究任务。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300036110.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0197","BK0196","BK0221","BK0042","300676"],"gpt_icon":0},{"id":"2577458362","title":"华大基因：未与沐曦在AI领域有合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2577458362","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577458362?lang=zh_cn&edition=full","pubTime":"2025-10-22 20:48","pubTimestamp":1761137332,"startTime":"0","endTime":"0","summary":"证券之星消息，华大基因(300676)10月21日在投资者关系平台上答复投资者关心的问题。投资者提问：汪总过往非常关注AI，IT+BT，那么公司是否与沐曦在AI领域有合作？是否投资了沐曦？华大基因回复：您好，感谢您对华大基因的关注。公司未与沐曦在AI领域有合作，未投资沐曦。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200035888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0046","BK0196","BK0042","300676","BK0221"],"gpt_icon":0},{"id":"2577362106","title":"华大基因：股东减持期间为2025年9月4日—2025年12月3日","url":"https://stock-news.laohu8.com/highlight/detail?id=2577362106","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577362106?lang=zh_cn&edition=full","pubTime":"2025-10-22 20:48","pubTimestamp":1761137332,"startTime":"0","endTime":"0","summary":"证券之星消息，华大基因10月21日在投资者关系平台上答复投资者关心的问题。根据公司2025年8月13日披露的《关于持股5%以上股东减持股份计划的预披露公告》，公司股东深圳生华投资企业减持期间为2025年9月4日—2025年12月3日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200035891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0221","300676","BK0046","BK0197","BK0196","BK0042"],"gpt_icon":0},{"id":"2574434117","title":"新股前瞻|带着40亿估值二次递表，安诺优达能否成为“港市华大基因”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2574434117","media":"智通财经","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574434117?lang=zh_cn&edition=full","pubTime":"2025-10-10 10:27","pubTimestamp":1760063226,"startTime":"0","endTime":"0","summary":"根据两家公司财报，NIPT业务收入大幅下滑是造成其营收波动的重要原因。所以此次是该公司的二次递表。根据招股书显示，截至2023年末于中国提供获国家药监局批准的NIPT检测试剂盒的公司中，排名前三的市场份额分别为50.5%、15.9%和12.1%，安诺优达的样本市场份额排名第三。也就是说，安诺优达在三年半累计亏损约4.62亿元，而其亏损主要源于高额的运营开支和财务成本。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1353476.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300676","BK0042","BK0221","BK0196","BK0197","BK0046"],"gpt_icon":0},{"id":"2569787601","title":"华大基因：9月22日高管汪建减持股份合计1673.27万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2569787601","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569787601?lang=zh_cn&edition=full","pubTime":"2025-09-22 21:01","pubTimestamp":1758546099,"startTime":"0","endTime":"0","summary":"证券之星消息，根据9月22日市场公开信息、上市公司公告及交易所披露数据整理，华大基因最新董监高及相关人员股份变动情况：2025年9月22日公司董事长汪建共减持公司股份1673.27万股，占公司总股本为4.0%。华大基因近半年内的董监高及核心技术人员增减持详情如下：华大基因的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流入6486.73万，融资余额增加；融券净流出1.41万，融券余额减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092200032684.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0197","BK0221","BK0042","300676","BK0196"],"gpt_icon":0},{"id":"2568404021","title":"股市必读：华大基因（300676）9月18日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2568404021","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568404021?lang=zh_cn&edition=full","pubTime":"2025-09-19 00:54","pubTimestamp":1758214456,"startTime":"0","endTime":"0","summary":"截至2025年9月18日收盘，华大基因报收于51.05元，下跌1.43%，换手率3.41%，成交量14.2万手，成交额7.38亿元。董秘最新回复投资者： 公司股价长期大跌，建议回购注销董秘： 您好，感谢您对华大基因的关注及建议。2025 年上半年，华大基因实现归母净利润 577.82 万元 。当日关注点来自“交易信息汇总”：9月18日主力资金净流入6327.61万元，显示主力对华大基因当日交易较为积极。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091900000849.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0197","BK0196","BK0221","BK0042","300676"],"gpt_icon":0},{"id":"2568427490","title":"华大基因：i99智健系统拓展精准健康管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2568427490","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568427490?lang=zh_cn&edition=full","pubTime":"2025-09-18 16:39","pubTimestamp":1758184764,"startTime":"0","endTime":"0","summary":"证券之星消息，华大基因09月18日在投资者关系平台上答复投资者关心的问题。2025 年上半年，华大基因实现归母净利润 577.82 万元 。公司在今年发布的基于“133111i”核心技术支撑的“i99智健系统”，将助力公司的业务从精准医学领域全面延伸至精准健康管理领域，进一步拓展业务边界，提升服务价值。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091800025585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300676","BK0197","BK0046","BK0042","BK0196","BK0221"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1768317221301,"stockEarnings":[{"period":"1week","weight":0.153},{"period":"1month","weight":0.1967},{"period":"3month","weight":0.1353},{"period":"6month","weight":0.0896},{"period":"1year","weight":0.4164},{"period":"ytd","weight":0.2059}],"compareEarnings":[{"period":"1week","weight":0.0353},{"period":"1month","weight":0.0709},{"period":"3month","weight":0.0776},{"period":"6month","weight":0.1888},{"period":"1year","weight":0.3146},{"period":"ytd","weight":0.0495}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳华大基因股份有限公司","boardCode":"AI0074","boardName":"专业技术服务业","stockholders":"67903人(较上一季度增加5.58%)","perCapita":"6127股","listingDate":"2017-07-14","address":"广东省深圳市盐田区梅沙街道滨海社区云华路9号华大时空中心B栋8南1-1","registeredCapital":"41831万元","survey":" 深圳华大基因股份有限公司的主营业务是为科研机构、企事业单位、医疗机构、社会卫生组织等提供研究服务、精准医学检测综合解决方案和健康管理服务。公司的主要产品是生育健康基础研究和临床应用服务、肿瘤与慢病防控及转化医学类服务、感染防控基础研究和临床应用服务、多组学大数据服务与合成业务、精准医学检测综合解决方案。","listedPrice":13.64},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华大基因(300676)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华大基因(300676)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华大基因,300676,华大基因股票,华大基因股票老虎,华大基因股票老虎国际,华大基因行情,华大基因股票行情,华大基因股价,华大基因股市,华大基因股票价格,华大基因股票交易,华大基因股票购买,华大基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华大基因(300676)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华大基因(300676)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}